Skip to content

Study evaluating preference, satisfaction and ease of use of inhalers in COPD diagnosed patients

Study evaluating preference, satisfaction and ease of use of inhalers in COPD diagnosed patients - Genuair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35964
Enrollment
60
Registered
2011-04-27
Start date
2011-06-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive lung disease smokers lung

Interventions

None listed

Sponsors

Almirall
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: male or female aged > 39 years stable COPD naïve to the study inhalers

Exclusion criteria

Exclusion criteria: clinical significant disease, particular body malformations of diseases affecting coordination and/or motor system (e.g. malformations or lack of upper extremities, Any disease that may affect the proper handling of the inhalers (Wilson*s disease, Stroke, Parkinson, Huntington*s Chorea...) ;unable to read product package instructions and to answer questionnaires

Design outcomes

Primary

MeasureTime frame
The primary variable is the percentage of patients who prefer the new inhaler at visit 2.

Secondary

MeasureTime frame
The secundary outcome ease of use convenience ease of learning to use ease of holding ease of operating ease of preparation of the dose feedback to indicate correct inhalation dosage

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)